PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA. (23rd June 2022) - Paul, B.; Liedtke, M.; Siegel, D. S.; Khouri, J.; Hillenglass, J.; Rifkin, R.; Gandhi, M. D.; Kin, A.; Levy, M. Y.; Mohrbacher, A.; Schmidt, W.; Silbermann, R.; et al.